Established and Emerging Strategies in the Treatment of Chronic Kidney Disease

Area of Science:

• Nephrology
• Public Health

Background:

• Chronic kidney disease (CKD) is a widespread health issue.
• Current treatments like renin-angiotensin system blockade, blood pressure, and glycemic control are insufficient for many patients, leading to disease progression.
• There is a need for improved CKD management strategies.

Purpose of the Study:

• To review established and emerging therapies for chronic kidney disease (CKD).
• To discuss the evidence and knowledge gaps for current and novel CKD treatments.
• To focus on interventions currently under investigation in randomized trials.

Main Methods:

• Review of existing literature on CKD treatments.
• Analysis of evidence for established therapies.
• Evaluation of newer strategies targeting inflammation and fibrosis.
• Focus on interventions being assessed in ongoing randomized trials.

Main Results:

• Established therapies, while foundational, do not prevent disease progression in a significant portion of the CKD population.
• Emerging strategies aimed at reducing inflammation and fibrosis have shown potential in preclinical and early-stage studies.
• Adequately powered randomized trials are essential to validate the efficacy and safety of these novel approaches.

Conclusions:

• Current CKD management requires enhancement beyond established protocols.
• Novel therapeutic avenues focusing on inflammation and fibrosis warrant further investigation through robust clinical trials.
• Optimizing CKD treatment necessitates a comprehensive understanding of both current limitations and future therapeutic possibilities.